A nomogram consisting of preoperative prostate-specific antigen (PSA), PSA at the time of biochemical recurrence (BCR), the time to BCR, and pathological features, was established and validated to predict the risk of cancer specific mortality after radical prostatectomy (17). This evidence concerns the gene KLK3 and cancer.